These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12831635)

  • 41. Insulin binding to antibodies is a risk factor for inexplicable severe hypoglycaemia in children with type-1 diabetes mellitus.
    Seewi O; Jaeger C; Bretzel RG; Schönau E
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):293-7. PubMed ID: 18484562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Retrospective analysis of the incidence of severe hypoglycemia in 458 type 1 diabetic patients].
    Bali C; Gurdet C; Irsigler K
    Acta Med Austriaca; 1997; 24(5):165-9. PubMed ID: 9480616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes.
    Karges B; Kapellen T; Wagner VM; Steigleder-Schweiger C; Karges W; Holl RW; Rosenbauer J;
    Pediatr Diabetes; 2017 Feb; 18(1):51-58. PubMed ID: 26712064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
    Blasetti A; Di Giulio C; Tocco AM; Verrotti A; Tumini S; Chiarelli F; Altobelli E
    Pediatr Diabetes; 2011 Feb; 12(1):4-10. PubMed ID: 20723102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors.
    Beregszàszi M; Tubiana-Rufi N; Benali K; Noël M; Bloch J; Czernichow P
    J Pediatr; 1997 Jul; 131(1 Pt 1):27-33. PubMed ID: 9255188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM.
    Hoffman RP; Singer-Granick C; Drash AL; Becker DJ
    Diabetes Care; 1991 Feb; 14(2):81-8. PubMed ID: 2060427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the use of analogue insulins in 37 206 children and adolescents with type 1 diabetes in 275 German and Austrian centers during the last twelve years.
    Kapellen TM; Wolf J; Rosenbauer J; Stachow R; Ziegler R; Szczepanski R; Holl RW;
    Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):329-35. PubMed ID: 19301233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors.
    Bhatia V; Wolfsdorf JI
    Pediatrics; 1991 Dec; 88(6):1187-93. PubMed ID: 1956736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.
    Braun D; Konrad D; Lang-Muritano M; Schoenle E
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):382-7. PubMed ID: 18331413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avoiding hypoglycemia: the use of insulin pump combined with continuous glucose monitor in type 1 diabetes crossing a Rocky Gorge.
    Thomakos P; Vazeou A; Sakkas D; Panagopoulos G; Anifantakis K; Smyrnaki P; Arvanitaki T; Kyrlaki E; Kefalogiannis N; Mamoulakis D; Pappas A; Mitrakou A
    QJM; 2018 Sep; 111(9):629-633. PubMed ID: 29939323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.
    Hissa MN; Hissa AS; Bruin VM; Fredrickson LP
    Endocr Pract; 2002; 8(6):411-6. PubMed ID: 15251830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.
    Mullins P; Sharplin P; Yki-Jarvinen H; Riddle MC; Haring HU
    Clin Ther; 2007 Aug; 29(8):1607-19. PubMed ID: 17919543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
    Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
    Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
    Holcombe JH; Zalani S; Arora VK; Mast CJ;
    Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
    Home PD; Rosskamp R; Forjanic-Klapproth J; Dressler A;
    Diabetes Metab Res Rev; 2005; 21(6):545-53. PubMed ID: 16021649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.
    Vague P; Selam JL; Skeie S; De Leeuw I; Elte JW; Haahr H; Kristensen A; Draeger E
    Diabetes Care; 2003 Mar; 26(3):590-6. PubMed ID: 12610006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of autoimmune hypoglycemia complicated with diabetic ketoacidosis.
    Shim MS; Kim MY; Kim MJ; Lee Y; Lee BJ; Chung CH; Shin YG
    Yonsei Med J; 2004 Feb; 45(1):140-4. PubMed ID: 15004881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.